By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > How long do you take buprenorphine for?

How long do you take buprenorphine for?

Answers by TheMediTary.Com - Last updated: 13-Jul-2023

There is no one-size-fits-all treatment duration for patients taking buprenorphine. There are many factors involved in determining the length of treatment when administering buprenorphine. These can include:

  • The condition being treated
  • The age and general health of the patient
  • The risk of opioid dependence

Based on these variables, a clinician will determine the proper dosage and length of treatment based on an individual’s specific needs.

Oral Buprenorphine

When prescribed by a clinician for the treatment of opioid dependence, buprenorphine (often administered as a sublingual tablet to be dissolved under the tongue) is given over two phases of treatment, known as induction and maintenance.

  1. Induction is the first phase, which uses a larger dose of buprenorphine for several days (on average, two to four days) to focus on reducing and stabilizing any immediate withdrawal symptoms that the patient may be experiencing while weaning off an opioid.
  2. Once the patient has stabilized, they can begin the maintenance phase. This involves the continued administration of buprenorphine at a lower dosage, often taken in combination with naloxone, in order to minimize withdrawal symptoms and reduce overall dependency. This phase may be long-term, allowing the patient time to complete an addiction treatment program.

Additionally, following the maintenance phase, a patient should be slowly weaned off buprenorphine using a calculated dosage reduction rate over the course of several days to weeks in order to avoid further opioid-related withdrawal symptoms. This rate will be patient-dependent and can vary in both dosage strength and length of administration.

Injectable Buprenorphine

The injectable form of buprenorphine is most commonly prescribed for the management of moderate-to-severe pain.

  • Administration of injectable buprenorphine can be intravenous or intramuscular.
  • Both intravenous and intramuscular buprenorphine are typically given by a slow injection over two minutes up to every six hours as needed for pain.

As there is the opportunity for misuse of buprenorphine, as with any opioid, it is important for patients to strictly adhere to their prescribed dosing schedule.

Share this Article

Featured questions

  • Butrans - My first time taking Belbuca and I am wanting to cut it in half to take 75 mg to see...
  • Buprenorphine - What will happen if I cut a Belbuca strip in half and take it when it's cut ?
  • Is Belbuca a controlled substance?
  • Belbuca - How Long should it take until I can feel the effects of it working?
  • Buprenorphine - what dose Belbuca do I need?
  • 150 mcg would be equal how many mg?
  • Does Belbuca cause weight gain? I'm on 75mcg twice a day for a week now Gained like 6-8 pounds.?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
  • What is the consideration to use nifidepine over amlodipine?
  • Hypertrophic cardiomyopathy/mechanical heart valve?
  • I have been on 400mg of tramadol a day for 20 years, decided its time to come off them
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by